Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 24655527)

1.

Oral graft-versus-host disease.

Kuten-Shorrer M, Woo SB, Treister NS.

Dent Clin North Am. 2014 Apr;58(2):351-68. doi: 10.1016/j.cden.2013.12.007. Review.

PMID:
24655527
2.

[Non-Invasive Diagnosis of Ocular Graft-versus-Host Disease].

Siebelmann S, Jing B, Cursiefen C, Steven P.

Klin Monbl Augenheilkd. 2015 May;232(5):652-7. doi: 10.1055/s-0035-1545830. Epub 2015 May 19. German.

PMID:
25989034
4.

MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation.

Tomuleasa C, Fuji S, Cucuianu A, Kapp M, Pileczki V, Petrushev B, Selicean S, Tanase A, Dima D, Berindan-Neagoe I, Irimie A, Einsele H.

Ann Hematol. 2015 Jul;94(7):1081-92. doi: 10.1007/s00277-015-2369-0. Epub 2015 Apr 22.

PMID:
25900787
5.

ST2: the biomarker at the heart of GVHD severity.

Ito S, Barrett AJ.

Blood. 2015 Jan 1;125(1):10-1. doi: 10.1182/blood-2014-11-611780. No abstract available.

PMID:
25554746
6.

Female genital tract chronic graft-versus-host disease: review of the literature.

Ciavattini A, Clemente N.

Anticancer Res. 2015 Jan;35(1):13-7. Review.

PMID:
25550529
7.

How we treat chronic graft-versus-host disease.

Flowers ME, Martin PJ.

Blood. 2015 Jan 22;125(4):606-15. doi: 10.1182/blood-2014-08-551994. Epub 2014 Nov 14. Review.

PMID:
25398933
8.

Liver disease after hematopoietic cell transplantation in adults.

Norvell JP.

Transplant Rev (Orlando). 2015 Jan;29(1):8-15. doi: 10.1016/j.trre.2014.08.001. Epub 2014 Aug 27.

PMID:
25315987
9.

Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host disease.

Bettinger D, Schorb E, Huzly D, Panning M, Schmitt-Graeff A, Kurz P, Bertz H, Finke J, Brass V, Thimme R, Hasselblatt P.

Ann Hematol. 2015 Feb;94(2):359-60. doi: 10.1007/s00277-014-2163-4. Epub 2014 Jul 13. No abstract available.

PMID:
25015055
10.

New insight for the diagnosis of gastrointestinal acute graft-versus-host disease.

Malard F, Mohty M.

Mediators Inflamm. 2014;2014:701013. doi: 10.1155/2014/701013. Epub 2014 Mar 11. Review.

11.

Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis.

Nakamura R, Forman SJ.

Expert Rev Hematol. 2014 Jun;7(3):407-21. doi: 10.1586/17474086.2014.898561. Epub 2014 Apr 4. Review.

PMID:
24702163
12.

Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.

Yeh AC, Brunner AM, Spitzer TR, Chen YB, Coughlin E, McAfee S, Ballen K, Attar E, Caron M, Preffer FI, Yeap BY, Dey BR.

Biol Blood Marrow Transplant. 2014 May;20(5):730-4. doi: 10.1016/j.bbmt.2014.02.003. Epub 2014 Feb 12.

13.

Review of therapies for the treatment of oral chronic graft-versus-host disease.

Granitto MH, Fall-Dickson JM, Norton CK, Sanders C.

Clin J Oncol Nurs. 2014 Feb;18(1):76-81. doi: 10.1188/14.CJON.76-81. Review.

PMID:
24476728
14.

A "window of opportunity" for patients with late-onset pulmonary dysfunction after allogeneic hematopoietic cell transplantation.

Cooke KR.

Biol Blood Marrow Transplant. 2014 Mar;20(3):291-2. doi: 10.1016/j.bbmt.2014.01.008. Epub 2014 Jan 25. No abstract available.

15.

Graft-versus-host disease: why have we not made more progress?

Jaglowski SM, Devine SM.

Curr Opin Hematol. 2014 Mar;21(2):141-7. doi: 10.1097/MOH.0000000000000026. Review.

16.

Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.

Moon JH, Sohn SK, Lambie A, Ellis L, Hamad N, Uhm J, Gupta V, Lipton JH, Messner HA, Kuruvilla J, Kim D.

Biol Blood Marrow Transplant. 2014 Apr;20(4):556-63. doi: 10.1016/j.bbmt.2014.01.010. Epub 2014 Jan 18.

17.

Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: a retrospective case series of 37 patients.

Si Y, Yang K, Qin M, Zhang C, Du Z, Zhang X, Liu Y, Yue Y, Feng Z.

Pediatr Hematol Oncol. 2014 Feb;31(1):39-49. doi: 10.3109/08880018.2013.867556. Epub 2014 Jan 2.

PMID:
24383400
18.

Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.

Devillier R, Fürst S, El-Cheikh J, Castagna L, Harbi S, Granata A, Crocchiolo R, Oudin C, Mohty B, Bouabdallah R, Chabannon C, Stoppa AM, Charbonnier A, Broussais-Guillaumot F, Calmels B, Lemarie C, Rey J, Vey N, Blaise D.

Biol Blood Marrow Transplant. 2014 Mar;20(3):370-4. doi: 10.1016/j.bbmt.2013.11.030. Epub 2013 Dec 4.

19.

Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.

Ruutu T, Juvonen E, Remberger M, Remes K, Volin L, Mattsson J, Nihtinen A, Hägglund H, Ringdén O; Nordic Group for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2014 Jan;20(1):135-8. doi: 10.1016/j.bbmt.2013.10.014. Epub 2013 Oct 17.

20.

Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.

Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Takatsuka Y, Eto T, Miyazaki Y, Hidaka M, Uike N, Miyamoto T, Tsudo M, Sakamaki H, Morishima Y, Suzuki R, Utsunomiya A.

Biol Blood Marrow Transplant. 2013 Dec;19(12):1731-9. doi: 10.1016/j.bbmt.2013.09.014. Epub 2013 Sep 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk